MKI67 and neoplasm: Pre-treated tumors eventually reverted back to an ADRN phenotype as evidenced by comparable subtype marker gene expression (Supplementary Figure S7F), histology (Supplementary Figure S7G) and tumor cell proliferation (Ki67, Supplementary Figure S7G, H).